Upon reviewing the pricing of IFs from Canadian and Bubs in the U.S. market, it appears that Bubs products are competitively priced compared to some Canadian counterparts.
For instance, Bubs Essential Infant Formula is listed at $26.99A, while Niuriss Infant Formula, a Canadian brand, is priced at $41.99A .
This price difference, plus 20% tariffs added may lead U.S. consumers to opt for Bubs offerings due to their affordability.
Therefore, your statement that higher prices for Canadian IFs could drive U.S. consumers toward Bubs products holds merit.
Upon reviewing the pricing of IFs from Canadian and Bubs in the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $142.9M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 15.8¢ | $240.2K | 1.490M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 404981 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 82249 | 7 |
View Market Depth
| Last trade - 16.15pm 30/07/2025 (20 minute delay) ? |
| BUB (ASX) Chart |